Cell & Gene Therapy
Cell & Gene Supply Chain
From clinical to commercial, only Marken can seamlessly guide your cell and gene therapies through each stage of the biopharmaceutical logistics journey from vein-to-vein. To ensure cell and gene therapies are brought to market successfully, pharma and biotech companies must address logistical complexities within the clinical supply chain, which requires specialized solutions, industry-leading expertise and a rigorous control process coupled with advanced technology.
Marken’s unique cell and gene supply chain services feature industry-defining expertise consisting of specialized teams of biopharma industry and logistics specialists.
In addition, we provide direction on shifting regulatory and trade compliance guidelines and offer high-touch oversight from operations, project management, control tower, and quality teams.
Explore more about our cell and gene services below.
Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss your Cell Therapy Supply Chain needs. Contact us on +1-800-627-5361 (US) or email info@marken.com
Related resources
Mastering the Advanced Therapy Supply Chain
29 October 2024
The field of Advanced Therapy Medicinal Products (ATMPs) has seen monumental advancements in recent years, offering groundbreaking treatments for a…
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 2
20 September 2024
Part 2 of our Orchestrating Outcomes for Logistics interview series highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 1
20 September 2024
To drive supply chain digitalization, it’s essential to leverage data not only to address immediate challenges but to anticipate and prevent disruptions
Marken Delivers Life-Saving Gene Therapy Treatment Over 3,000 Miles From Germany to the UAE in Under 48 Hours
18 September 2024
Marken was tasked with delivering a life-saving gene therapy treatment for a child suffering from Duchenne muscular dystrophy (DMD) in…
Marken seamlessly orchestrates distribution of first commercial CAR-T therapy drug product from USA to Japan
17 October 2023
Marken successfully orchestrated the distribution of the first commercial CAR-T therapy drug product from the USA to a hospital in…
Marken’s 24/7 Cell & Gene Control Tower Provides Agile Solution for Critical Shipments
9 February 2023
Marken’s Cell and Gene Control Tower re-routed six critical shipments of CAR-T drug products from Amsterdam to the UK and…
Operational Excellence Overcomes Obstacles to Deliver Critical Autologous Cell Therapy
9 February 2023
Marken utilized operational excellence to deliver a critical autologous cell therapy. Although there were many challenges, Marken was able to…
Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours
4 January 2023
The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…
Happy Holidays from Marken
21 December 2022
At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…
Marken Overcomes Multiple Obstacles To Successfully Deliver Critical Stem Cell Samples Across The Globe
9 December 2022
Stem cell samples require extremely tight 24-hour turnaround times in order to be modified and processed for critical cell therapy…
The Complex Demands of Personalized Medicine Supply Chains.
26 July 2021
Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved…
Evaluating a Clinical Supply Chain Partner to Meet Your Vaccine Trial Needs.
23 April 2021
It is essential for pharmaceutical companies to evaluate many factors when choosing a clinical supply chain partner. With today’s global…
Delivering What Matters
Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.
Login and quick links